CVS Group (LON:CVSG) Sets New 1-Year High – Still a Buy?

CVS Group plc (LON:CVSGGet Free Report) shares reached a new 52-week high during trading on Friday . The stock traded as high as GBX 1,242 ($16.49) and last traded at GBX 1,224 ($16.25), with a volume of 1164404 shares trading hands. The stock had previously closed at GBX 1,076 ($14.28).

CVS Group Trading Up 4.0 %

The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.52. The company has a market capitalization of £911.94 million, a P/E ratio of 44.05, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The business has a fifty day moving average price of GBX 1,017.33 and a 200 day moving average price of GBX 942.84.

CVS Group (LON:CVSGGet Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported GBX 40 ($0.53) EPS for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. On average, analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current fiscal year.

Insider Activity

In other CVS Group news, insider Richard Gray sold 305 shares of CVS Group stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of GBX 1,007 ($13.37), for a total value of £3,071.35 ($4,076.65). Insiders own 5.83% of the company’s stock.

About CVS Group

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

Recommended Stories

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.